content

Quotient Sciences and Vasa Therapeutics Announce Dosing of First Subjects with VS-041, a Novel Heart Failure Treatment

VS-041, aย novelย and potentially life-savingย ย treatmentย forย heartย failure, developed byย Vasaย Therapeutics, a San Diego-based biotechnologyย  company, has reached a major clinical milestone with theย firstย humanย subjectsย dosed atย Quotientย ย Sciencesโ€™ Nottingham, UK clinic. In this...

Chicago Rockford International Airport (RFD) Announces New Pharma Trade Lane with First Pharma Air Cargo Import Shipment from India

Chicago Rockford International Airport (RFD) is pleased to announce the recent initiation of new GDP certified pharmaceutical trade lane from India. The first shipment...

Child-resistant packaging: navigating the delicate balance between security and inclusion

Within the highly regulated pharmaceutical industry, patient safety stands as an unwavering principle. Packaging design, in this context, assumes a critical role in safeguarding...

Nordic Biotech Company Raises Capital for New International Obesity Study

Nordicย biotechย companyย Pila Pharma, founded and chaired by former Novo Nordisk researcher Dorte X. Gram, has recently raised 10 million SEK in directed issue for a...

Hongene Biotech Corporation and ReciBioPharm establish a gene editing development partnership

Hongeneย Biotechย Corporation, a global leader in nucleic acid manufacturing, andย ReciBioPharm, a leading advanced therapeutics CDMO services provider, have announced a strategic collaboration that will enhanceย geneย editingย drug...

Symbiosis announces acquisition of new facility and investment in automated commercial scale GMP sterile manufacturing capability supported by ยฃ4.3m grant from Scottish Enterprise

Symbiosis Pharmaceutical Services Ltd (Symbiosis), a rapidly growing sterile biopharmaceutical Contract Manufacturing Organisation (CMO) announces the purchase of new premises in Stirling, Scotland, UK. The...

At CPHI Milan, TekniPlex Healthcare to Highlight New Solutions for Single-use Bioprocessing, Cell & Gene Therapies

Company also will provide live demos of next-generation automatic filler-sealer for single-dose plastic vials, and showcase sustainability-minded blister packaging, as well as other film...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read